@article{huerta_risk_2001,
	title = {The risk of obstructive airways disease in a glaucoma population},
	volume = {10},
	issn = {1053-8569},
	doi = {10.1002/pds.567},
	abstract = {BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD), defined as obstructive airways disease (OAD), are two common chronic conditions especially in the elderly. Glaucoma is also a common disease in the elderly with a prevalence close to 5\% among those older than 75 years. Most medical therapy for glaucoma is given as eye drops. It has been described that small amounts of systemically absorbed beta-blockers can produce significant respiratory adverse events in predisposed patients.
METHODS: Population-based cohort study with nested case-control analysis using the UK General Practice Research Database (GPRD). We studied the prevalence of OAD in a cohort of patients 60 to 85 years old with a first ever diagnosis of glaucoma and compared it to the prevalence in an age- and sex-matched cohort sampled from the general population. We also calculated the RR and 95\% CI of worsening asthma in non-severe asthma patients among the two cohorts. Incidence of OAD was studied in a cohort of glaucoma patients 60 to 85 years old and in an age- and sex-matched cohort from the general population.
RESULTS: The prevalence of OAD was the same between the glaucoma cohort and the general population (OR 1.1; 95\% CI 0.9-1.4). The risk of worsening asthma associated with glaucoma was OR 1.2 (95\% CI 0.5-2.8). The incidence of OAD was similar in both cohorts. Current users of ophthalmic drugs presented a RR of 1.2 (95\% CI 0.8-1.9) of developing asthma compared to non-users in the glaucoma population. The risk in the first month of treatment with topical beta-blockers was 2.1 (95\% CI 0.7-6.7).
DISCUSSION: We did not find an association between glaucoma and OAD. Use of topical glaucoma medication was not associated with a major increased risk of asthma.},
	language = {eng},
	number = {2},
	journal = {Pharmacoepidemiology and Drug Safety},
	author = {Huerta, C. and García Rodríguez, L. A. and Möller, C. S. and Arellano, F. M.},
	month = apr,
	year = {2001},
	pmid = {11499855},
	keywords = {Aged, Aged, 80 and over, Asthma, Case-Control Studies, Cohort Studies, Female, Glaucoma, Humans, Male, Middle Aged, Ophthalmic Solutions, Population Surveillance, Prevalence, Pulmonary Disease, Chronic Obstructive, Risk Factors, incidence},
	pages = {157--163}
}

{"_id":"Sq2c73ibTyWmw7mfj","bibbaseid":"huerta-garcarodrguez-mller-arellano-theriskofobstructiveairwaysdiseaseinaglaucomapopulation-2001","downloads":0,"creationDate":"2017-08-15T09:38:10.727Z","title":"The risk of obstructive airways disease in a glaucoma population","author_short":["Huerta, C.","García Rodríguez, L. A.","Möller, C. S.","Arellano, F. M."],"year":2001,"bibtype":"article","biburl":"http://bibbase.org/zotero/veegee78","bibdata":{"bibtype":"article","type":"article","title":"The risk of obstructive airways disease in a glaucoma population","volume":"10","issn":"1053-8569","doi":"10.1002/pds.567","abstract":"BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD), defined as obstructive airways disease (OAD), are two common chronic conditions especially in the elderly. Glaucoma is also a common disease in the elderly with a prevalence close to 5% among those older than 75 years. Most medical therapy for glaucoma is given as eye drops. It has been described that small amounts of systemically absorbed beta-blockers can produce significant respiratory adverse events in predisposed patients. METHODS: Population-based cohort study with nested case-control analysis using the UK General Practice Research Database (GPRD). We studied the prevalence of OAD in a cohort of patients 60 to 85 years old with a first ever diagnosis of glaucoma and compared it to the prevalence in an age- and sex-matched cohort sampled from the general population. We also calculated the RR and 95% CI of worsening asthma in non-severe asthma patients among the two cohorts. Incidence of OAD was studied in a cohort of glaucoma patients 60 to 85 years old and in an age- and sex-matched cohort from the general population. RESULTS: The prevalence of OAD was the same between the glaucoma cohort and the general population (OR 1.1; 95% CI 0.9-1.4). The risk of worsening asthma associated with glaucoma was OR 1.2 (95% CI 0.5-2.8). The incidence of OAD was similar in both cohorts. Current users of ophthalmic drugs presented a RR of 1.2 (95% CI 0.8-1.9) of developing asthma compared to non-users in the glaucoma population. The risk in the first month of treatment with topical beta-blockers was 2.1 (95% CI 0.7-6.7). DISCUSSION: We did not find an association between glaucoma and OAD. Use of topical glaucoma medication was not associated with a major increased risk of asthma.","language":"eng","number":"2","journal":"Pharmacoepidemiology and Drug Safety","author":[{"propositions":[],"lastnames":["Huerta"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["García","Rodríguez"],"firstnames":["L.","A."],"suffixes":[]},{"propositions":[],"lastnames":["Möller"],"firstnames":["C.","S."],"suffixes":[]},{"propositions":[],"lastnames":["Arellano"],"firstnames":["F.","M."],"suffixes":[]}],"month":"April","year":"2001","pmid":"11499855","keywords":"Aged, Aged, 80 and over, Asthma, Case-Control Studies, Cohort Studies, Female, Glaucoma, Humans, Male, Middle Aged, Ophthalmic Solutions, Population Surveillance, Prevalence, Pulmonary Disease, Chronic Obstructive, Risk Factors, incidence","pages":"157--163","bibtex":"@article{huerta_risk_2001,\n\ttitle = {The risk of obstructive airways disease in a glaucoma population},\n\tvolume = {10},\n\tissn = {1053-8569},\n\tdoi = {10.1002/pds.567},\n\tabstract = {BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD), defined as obstructive airways disease (OAD), are two common chronic conditions especially in the elderly. Glaucoma is also a common disease in the elderly with a prevalence close to 5\\% among those older than 75 years. Most medical therapy for glaucoma is given as eye drops. It has been described that small amounts of systemically absorbed beta-blockers can produce significant respiratory adverse events in predisposed patients.\nMETHODS: Population-based cohort study with nested case-control analysis using the UK General Practice Research Database (GPRD). We studied the prevalence of OAD in a cohort of patients 60 to 85 years old with a first ever diagnosis of glaucoma and compared it to the prevalence in an age- and sex-matched cohort sampled from the general population. We also calculated the RR and 95\\% CI of worsening asthma in non-severe asthma patients among the two cohorts. Incidence of OAD was studied in a cohort of glaucoma patients 60 to 85 years old and in an age- and sex-matched cohort from the general population.\nRESULTS: The prevalence of OAD was the same between the glaucoma cohort and the general population (OR 1.1; 95\\% CI 0.9-1.4). The risk of worsening asthma associated with glaucoma was OR 1.2 (95\\% CI 0.5-2.8). The incidence of OAD was similar in both cohorts. Current users of ophthalmic drugs presented a RR of 1.2 (95\\% CI 0.8-1.9) of developing asthma compared to non-users in the glaucoma population. The risk in the first month of treatment with topical beta-blockers was 2.1 (95\\% CI 0.7-6.7).\nDISCUSSION: We did not find an association between glaucoma and OAD. Use of topical glaucoma medication was not associated with a major increased risk of asthma.},\n\tlanguage = {eng},\n\tnumber = {2},\n\tjournal = {Pharmacoepidemiology and Drug Safety},\n\tauthor = {Huerta, C. and García Rodríguez, L. A. and Möller, C. S. and Arellano, F. M.},\n\tmonth = apr,\n\tyear = {2001},\n\tpmid = {11499855},\n\tkeywords = {Aged, Aged, 80 and over, Asthma, Case-Control Studies, Cohort Studies, Female, Glaucoma, Humans, Male, Middle Aged, Ophthalmic Solutions, Population Surveillance, Prevalence, Pulmonary Disease, Chronic Obstructive, Risk Factors, incidence},\n\tpages = {157--163}\n}\n\n","author_short":["Huerta, C.","García Rodríguez, L. A.","Möller, C. S.","Arellano, F. M."],"key":"huerta_risk_2001","id":"huerta_risk_2001","bibbaseid":"huerta-garcarodrguez-mller-arellano-theriskofobstructiveairwaysdiseaseinaglaucomapopulation-2001","role":"author","urls":{},"keyword":["Aged","Aged","80 and over","Asthma","Case-Control Studies","Cohort Studies","Female","Glaucoma","Humans","Male","Middle Aged","Ophthalmic Solutions","Population Surveillance","Prevalence","Pulmonary Disease","Chronic Obstructive","Risk Factors","incidence"],"downloads":0},"search_terms":["risk","obstructive","airways","disease","glaucoma","population","huerta","garcía rodríguez","möller","arellano"],"keywords":["aged","aged","80 and over","asthma","case-control studies","cohort studies","female","glaucoma","humans","male","middle aged","ophthalmic solutions","population surveillance","prevalence","pulmonary disease","chronic obstructive","risk factors","incidence"],"authorIDs":[],"dataSources":["FmCWXwJibZiWNzpdc"]}